skip to main content
Guest
My Research
My Account
Sign out
Sign in
This feature requires javascript
Library Search
Find Databases
Browse Search
E-Journals A-Z
E-Books A-Z
Citation Linker
Help
Language:
English
Vietnamese
This feature required javascript
This feature requires javascript
Primo Search
All Library Resources
All
Course Materials
Course Materials
Search For:
Clear Search Box
Search in:
All Library Resources
Or hit Enter to replace search target
Or select another collection:
Search in:
All Library Resources
Search in:
Print Resources
Search in:
Digital Resources
Search in:
Online E-Resources
Advanced Search
Browse Search
This feature requires javascript
Search Limited to:
Search Limited to:
Resource type
criteria input
All items
Books
Articles
Images
Audio Visual
Maps
Graduate theses
Show Results with:
criteria input
that contain my query words
with my exact phrase
starts with
Show Results with:
Search type Index
criteria input
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
Show Results with:
in the title
Show Results with:
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
This feature requires javascript
Structural recognition of carbohydrates by antibody candidates for immunotherapy of cancer and infection
Digital Resources/Online E-Resources
Citations
Cited by
View Online
Details
Recommendations
Reviews
Times Cited
External Links
This feature requires javascript
Actions
Add to My Research
Remove from My Research
E-mail
Print
Permalink
Citation
EasyBib
EndNote
RefWorks
Delicious
Export RIS
Export BibTeX
This feature requires javascript
Title:
Structural recognition of carbohydrates by antibody candidates for immunotherapy of cancer and infection
Author:
SOLIMAN, Caroline
Subjects:
Antibodies
;
Cancer
;
Carbohydrate-binding antibodies
;
Carbohydrates
;
Infection
;
Monoclonal antibodies
;
Structural biology
Description:
Monoclonal antibody therapies are increasingly being developed for the treatment of a range of diseases including cancer, and as therapies for infectious disease. While most of the approved therapeutic antibodies target protein or glycoprotein antigens, it has been known for many years that carbohydrate-binding antibodies are capable of specifically recognizing altered self-cells (e.g. cancer cells) and being effective in providing protective responses to pathogens. However, progress has been slow when delivering carbohydrate-binding monoclonal antibodies (mAbs) as therapeutics for cancer and for antibiotic resistant bacterial infections. The overall goal of this thesis is to determine the structural basis for recognition of carbohydrates by antibodies with potential uses in the immunotherapy of several cancers and a broad range of infections. This was done using a range of integrated computational and experimental techniques. Chapter 2 examines the three-dimensional structural basis for the effective targeting of a broadly expressed microbial polysaccharide, known as poly-N-acetyl glucosamine (PNAG). Crystal structures of the human anti-PNAG mAb F598 showed a large deep binding groove that accommodates at least 5 PNAG residues via an anchored binding mechanism, recognising the core GlcNAc residue in a conserved manner. This study revealed the mechanism for broad-spectrum antibody-based targeting of microbial pathogens by a fully human antibody. Chapters 3 and 5 identify two other carbohydrate-binding antibodies that are being developed as cancer therapeutics. Importantly, understanding the molecular details of glycan recognition may help advance a new class of cancer-targeting immunotherapy. In Chapter 3, the structural basis for the effective targeting of stage-specific embryonic antigen-4 (SSEA-4) is examined using crystallography and molecular dynamics. SSEA-4 is a glycan that is overexpressed on some cancer cells including breast and ovarian. The chimeric antibody ch28/11 was shown to be highly specific for SSEA-4, with X-ray structures revealing carbohydrate binding also occurred in a large deep binding groove, similar to F598-PNAG. SSEA-4 bound in a horseshoe-like conformation with the highly specific nature of the antibody explained by the dominant binding of the terminal sialic acid, as further supported by molecular dynamics simulations. Chapter 5 examines the structural basis for antibody binding to a group of Lewis glycans, which are overexpressed on many carcinomas, including those of the colon, lung, breast, prostate and ovary. The chimeric antibody ch88.2 showed reactivity to colorectal cancer cells and significantly reduced cell viability. Glycan recognition of the Lea-Lex hexasaccharide was predicted to occur in an extended but shallow groove by X-ray crystallography and computational techniques, in contrast to the binding observed for F598 and ch28/11. Interestingly, ch88.2 bound to both glycans, with one site for Lea and a second adjacent site for Lex. These results provide structural insights into the cross-reactivity of the ch88.2 mAb for various Lewis-a and Lewis-x containing glycans and its high selectivity for Lewis-positive tumours. Finally, to identify nanoscale imaging techniques that are appropriate for visualizing cancer cell membrane damage, a model peptide was employed in Chapter 4. Melittin, a bee-venom peptide with wide reaching cytotoxic effects, has the potential to be used as a targeted immunotherapy. Melittin was shown to cause rapid changes to colorectal and gastric cancer cells. High-resolution microscopy, membrane staining, AFM and SEM techniques all revealed extensive changes to cancer cells within seconds of melittin treatment in the form of cell swelling, membrane breakage and blebbing. These techniques were further employed in Chapter 5 to image antibody-induced nanoscale transformations of target cell membranes, where ch88.2 was observed to cause cancer cell death via pore formation. Overall, this thesis provides a detailed understanding of the 3D structural basis for recognition of carbohydrates by antibodies in cancer and bacterial infection, which may have future applications for the development of therapeutic antibodies. Source: TROVE
Creation Date:
2020
Language:
English
Source:
Trove Australian Thesis (Full Text Open Access)
This feature requires javascript
This feature requires javascript
Back to results list
This feature requires javascript
This feature requires javascript
Searching Remote Databases, Please Wait
Searching for
in
scope:(TDTS),scope:(SFX),scope:(TDT),scope:(SEN),primo_central_multiple_fe
Show me what you have so far
This feature requires javascript
This feature requires javascript